Linked color imaging versus lugol chromoendoscopy for screeninng of esophageal squamous cell neoplasia and precancerous lesions

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045636

Enrollment

Unknown

Registered

2021-04-20

Start date

2021-04-30

Completion date

Unknown

Last updated

2021-12-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

esophageal squamous cell neoplasia and precancerous lesions

Interventions

Gold Standard:Pathological results

Index test:Linked Color Imaging

Eligibility

Sex/Gender

All

Age

45 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Patient who were 45-85 years required endoscopic examination; 2. Agree to participate in this research activity and sign an informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with intolerance to Lugol staining endoscopy/iodine allergy/hyperthyroidism; 2. Endoscopy is taboo; 3. Anesthesia taboo; 4. It is forbidden to stop antiplatelet or anticoagulant drugs; 5. Patients with esophageal cancer who have received surgical resection, chemotherapy, and radiotherapy.

Design outcomes

Primary

Measure	Time frame
Sensitivity;Specificity;Detection rate of early esophageal cancer/precancerous lesions;	—

Countries

China

Contacts

Public ContactChai Ningli

The General Hospital of the People's Liberation Army

chainingli@vip.163.com+86 15011362982

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026